News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
308,692 Results
Type
Article (17270)
Company Profile (50)
Press Release (291370)
Multimedia
Podcasts (34)
Webinars (6)
Section
Business (81650)
Career Advice (694)
Deals (15067)
Drug Delivery (39)
Drug Development (43381)
Employer Resources (75)
FDA (7673)
Job Trends (6504)
News (149581)
Policy (14102)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1446)
Academic (1)
Accelerated approval (15)
Adcomms (10)
Allergies (77)
Alliances (21808)
ALS (101)
Alzheimer's disease (786)
Antibody-drug conjugate (ADC) (157)
Approvals (7994)
Artificial intelligence (307)
Autoimmune disease (83)
Automation (24)
Bankruptcy (124)
Best Places to Work (5557)
BIOSECURE Act (6)
Biosimilars (124)
Biotechnology (34)
Bladder cancer (120)
Brain cancer (33)
Breast cancer (416)
Cancer (2990)
Cardiovascular disease (254)
Career advice (600)
Career pathing (14)
CAR-T (143)
CDC (25)
Celiac Disease (1)
Cell therapy (399)
Cervical cancer (25)
Clinical research (38647)
Collaboration (1006)
Company closure (1)
Compensation (477)
Complete response letters (22)
COVID-19 (2274)
CRISPR (58)
C-suite (458)
Cystic fibrosis (62)
Data (4117)
Denatured (9)
Depression (76)
Diabetes (272)
Diagnostics (3274)
Digital health (25)
Diversity (9)
Diversity, equity & inclusion (29)
Drug discovery (133)
Drug pricing (76)
Drug shortages (19)
Duchenne muscular dystrophy (130)
Earnings (33137)
Editorial (29)
Employer branding (6)
Employer resources (68)
Events (44272)
Executive appointments (609)
FDA (9652)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (3)
Frontotemporal dementia (11)
Funding (845)
Gene editing (102)
Generative AI (20)
Gene therapy (321)
GLP-1 (489)
Government (2163)
Grass and pollen (4)
Guidances (248)
Healthcare (8580)
HIV (47)
Huntington's disease (26)
IgA nephropathy (37)
Immunology and inflammation (92)
Immuno-oncology (27)
Indications (62)
Infectious disease (2468)
Inflammatory bowel disease (101)
Inflation Reduction Act (8)
Influenza (94)
Intellectual property (109)
Interviews (114)
IPO (6287)
IRA (25)
Job creations (1237)
Job search strategy (520)
JPM (19)
Kidney cancer (11)
Labor market (26)
Layoffs (144)
Leadership (18)
Legal (2932)
Liver cancer (50)
Longevity (5)
Lung cancer (423)
Lymphoma (243)
Machine learning (20)
Management (23)
Manufacturing (390)
MASH (96)
Medical device (5535)
Medtech (5562)
Mergers & acquisitions (9443)
Metabolic disorders (642)
Multiple sclerosis (107)
NASH (16)
Neurodegenerative disease (153)
Neuropsychiatric disorders (37)
Neuroscience (1465)
NextGen: Class of 2026 (2602)
Non-profit (2154)
Now hiring (17)
Obesity (265)
Opinion (145)
Ovarian cancer (104)
Pain (113)
Pancreatic cancer (131)
Parkinson's disease (146)
Partnered (16)
Patents (194)
Patient recruitment (274)
Peanut (27)
People (26367)
Pharmaceutical (12)
Pharmacy benefit managers (16)
Phase 1 (10213)
Phase 2 (16672)
Phase 3 (14559)
Pipeline (3143)
Policy (123)
Postmarket research (1573)
Preclinical (3877)
Press Release (59)
Prostate cancer (153)
Psychedelics (22)
Radiopharmaceuticals (123)
Rare diseases (431)
Real estate (2344)
Recruiting (26)
Regulatory (11535)
Reports (18)
Research institute (1376)
Resumes & cover letters (92)
Rett syndrome (22)
RNA editing (4)
RSV (53)
Schizophrenia (74)
Series A (146)
Series B (111)
Service/supplier (4)
Sickle cell disease (51)
Special edition (7)
Spinal muscular atrophy (91)
Sponsored (15)
Startups (1510)
State (1)
Stomach cancer (6)
Supply chain (54)
Tariffs (20)
The Weekly (25)
Vaccines (657)
Venture capital (30)
Weight loss (152)
Women's health (43)
Worklife (8)
Date
Today (23)
Last 7 days (267)
Last 30 days (1109)
Last 365 days (17071)
2026 (1899)
2025 (17511)
2024 (16486)
2023 (17152)
2022 (23079)
2021 (25573)
2020 (25106)
2019 (20214)
2018 (15334)
2017 (14247)
2016 (13730)
2015 (16415)
2014 (11718)
2013 (9525)
2012 (10501)
2011 (11065)
2010 (10286)
Location
Africa (366)
Alabama (26)
Alaska (4)
Arizona (95)
Arkansas (5)
Asia (18642)
Australia (3093)
California (5747)
Canada (1612)
China (631)
Colorado (261)
Connecticut (309)
Delaware (248)
Europe (47112)
Florida (713)
Georgia (213)
Hawaii (3)
Idaho (20)
Illinois (507)
India (40)
Indiana (229)
Iowa (12)
Japan (340)
Kansas (55)
Kentucky (19)
Louisiana (14)
Maine (18)
Maryland (643)
Massachusetts (4228)
Michigan (113)
Minnesota (289)
Mississippi (1)
Missouri (63)
Montana (7)
Nebraska (12)
Nevada (77)
New Hampshire (84)
New Jersey (2970)
New Mexico (24)
New York (1819)
North Carolina (1467)
North Dakota (10)
Northern California (2769)
Ohio (141)
Oklahoma (7)
Oregon (15)
Pennsylvania (1043)
Puerto Rico (7)
Rhode Island (19)
South America (574)
South Carolina (14)
South Dakota (1)
Southern California (2187)
Tennessee (83)
Texas (874)
United States (22505)
Utah (103)
Virginia (141)
Washington D.C. (27)
Washington State (475)
West Virginia (2)
Wisconsin (98)
Wyoming (2)
308,692 Results for "pharming group n v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 17, 2026
·
1 min read
Press Releases
Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
February 3, 2026
·
7 min read
Press Releases
Pharming Group reports preliminary 2025 revenues and announces Investor Day
January 8, 2026
·
5 min read
Press Releases
Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit
December 8, 2025
·
1 min read
Press Releases
Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS
February 2, 2026
·
8 min read
Press Releases
Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London
October 30, 2025
·
1 min read
Press Releases
Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences
January 7, 2026
·
3 min read
Pharming Group to participate in June 2024 investor conferences
Leiden, the Netherlands, June 3, 2024: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of June:.
June 3, 2024
·
1 min read
Press Releases
Pharming Group appoints Kenneth Lynard as Chief Financial Officer
September 2, 2025
·
5 min read
Pharming Group to participate in May 2024 investor conference
Leiden, the Netherlands, May 20, 2024: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conference in the month of May.
May 20, 2024
·
1 min read
1 of 30,870
Next
